Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Biosens Bioelectron ; 213: 114440, 2022 Oct 01.
Article in English | MEDLINE | ID: covidwho-1866916

ABSTRACT

It has been found that the direct/total bilirubin ratio (D/T-BIL) is related to the survival rate of COVID-19 pneumonia. The presence of an excessive amount of bilirubin in human blood also causes liver and neurological damage, leading to death. Therefore, upon considering the adverse impact of the presence of excessive bilirubin in human blood, it has become highly imperative to detect bilirubin in a fast and label-free manner. Herein, we designed and constructed a random-crossed-woodpile nanostructure from silver nanowires to form a 3-dimensional plasmonic hotspot-rich (3D-PHS) nanostructure and successfully used it to detect direct bilirubin (D-BIL) in human blood in a label-free manner. The 3D-PHS nanochip provides rich spatial hot spots that are simultaneously responsive to SERS and SPEF effects and consequently, successfully used to measure and characterize D-BIL with a detection limit of ∼10 nM, requiring only 10µL of human serum for rapid screening, which is the first time D-BIL has been detected in a clinically relevant range. This demonstrates a simple, label-free, pretreatment-free potential biosensing technology that can be used in health care units, and further, in the efficient detection of point-of-care testing with a portable spectrometer.


Subject(s)
Biosensing Techniques , COVID-19 , Metal Nanoparticles , Nanowires , Bilirubin , COVID-19/diagnosis , Delivery of Health Care , Humans , Metal Nanoparticles/chemistry , Nanowires/chemistry , Silver/chemistry , Spectrum Analysis, Raman/methods
2.
Biosens Bioelectron ; 177: 112672, 2021 Apr 01.
Article in English | MEDLINE | ID: covidwho-844839

ABSTRACT

Accurate, rapid, and low-cost molecular diagnostics is essential in managing outbreaks of infectious diseases, such as the pandemic of coronavirus disease 2019 (COVID-19). Accordingly, microfluidic paper-based analytical devices (µPADs) have emerged as promising diagnostic tools. Among the extensive efforts to improve the performance and usability of diagnostic tools, biosensing mechanisms based on electrochemical impedance spectroscopy (EIS) have shown great promise because of their label-free operation and high sensitivity. However, the method to improve EIS biosensing on µPADs is less explored. Here, we present an experimental approach to enhancing the performance of paper-based EIS biosensors featuring zinc oxide nanowires (ZnO NWs) directly grown on working electrodes (WEs). Through a comparison of different EIS settings and an examination of ZnO-NW effects on EIS measurements, we show that ZnO-NW-enhanced WEs function reliably with Faradaic processes utilizing iron-based electron mediators. We calibrate paper-based EIS biosensors with different morphologies of ZnO NWs and achieve a low limit of detection (0.4 pg ml-1) in detecting p24 antigen as a marker for human immunodeficiency virus (HIV). Through microscopic imaging and electrochemical characterization, we reveal that the morphological and the electrochemical surface areas of ZnO-NW-enhanced WEs indicate the sensitivities and sensing ranges of the EIS nanobiosensors. Finally, we report that the EIS nanobiosensors are capable of differentiating the concentrations (blank, 10 ng ml-1, 100 ng ml-1, and 1 µg ml-1) of IgG antibody (CR3022) to SARS-CoV-2 in human serum samples, demonstrating the efficacy of these devices for COVID-19 diagnosis. This work provides a methodology for the rational design of high-performance EIS µPADs and has the potential to facilitate diagnosis in pandemics.


Subject(s)
Biosensing Techniques/instrumentation , COVID-19 Serological Testing/instrumentation , COVID-19/diagnosis , Dielectric Spectroscopy/instrumentation , SARS-CoV-2/isolation & purification , Biosensing Techniques/methods , COVID-19/blood , COVID-19 Serological Testing/methods , Dielectric Spectroscopy/methods , Equipment Design , Humans , Lab-On-A-Chip Devices , Limit of Detection , Nanowires/chemistry , Paper , Zinc Oxide/chemistry
3.
Electromagn Biol Med ; 39(4): 340-346, 2020 Oct 01.
Article in English | MEDLINE | ID: covidwho-707219

ABSTRACT

All therapeutic methods dealing with coronavirus (past and present) are based on chemicals. We test for it (positive or negative) chemically and hope to cure it with a future vaccine (some complicated chemical preparation). If and when the virus mutates, another set of chemical protocols for its testing and a hunt for new chemicals as a vaccine shall begin again and again. But the history of modern (western) medicine tells us that our biotechnology is not so limited. Copious scientific evidence for sonic and low energy electromagnetic signals produced by all biological elements (DNA, cells, bacteria, parasites, virus) exists; in turn, the biological elements are affected by these non-chemical signals as well. A careful analysis and a catalogue of the spectrum of these non-chemical signals are proposed here as a unique biophysical signature.


Subject(s)
Betacoronavirus/physiology , Coronavirus Infections/virology , Models, Biological , Pneumonia, Viral/virology , Radio Waves , Bacterial Physiological Phenomena , Biophysical Phenomena , COVID-19 , DNA/chemistry , Electromagnetic Phenomena , Humans , Microbial Interactions/physiology , Nanowires/chemistry , Pandemics , SARS-CoV-2 , Signal Transduction/physiology , Ultrasonics , Water/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL